Abivax Rebounds: How Positive Phase III Data and a Strategic Capital Raise Reset the Narrative for Obefazimod
In the high-stakes world of biotechnology, investor sentiment can pivot on a single data point. For Paris-based Abivax (Euronext Paris...
abivax
Abivax’s Rollercoaster Week: Obefazimod’s Clinical Triumph Overshadowed by Safety Skepticism
In the high-stakes world of biotechnology, few events can trigger a market reaction as violent as the intersection of stellar...
